TOMORROW'S DIAGNOSTICS, TODAY
Safeguarding against the spread of antimicrobial resistance worldwide.
TOMORROW'S DIAGNOSTICS, TODAY
Safeguarding against the spread of antimicrobial resistance worldwide.
Our Technology
By 2050, there could be 10 million deaths from antimicrobial resistance (AMR).
Microplate Dx offers a true solution for rapid antibiotic susceptibility testing (AST). We combine ground-breaking hardware with novel data processing algorithms to perform rapid antibiotic susceptibility testing for urinary tract infections.
Our innovative RapidPlate technology achieved 96% accuracy with a 30-minute time to result in a pre-clinical study, with a recent £2.5 million investment round for further development.